These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36406319)

  • 1. Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma.
    Huang Z; Xia H; Cui Y; Yam JWP; Xu Y
    J Clin Transl Hepatol; 2023 Feb; 11(1):207-218. PubMed ID: 36406319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Targets of Ferroptosis in Hepatocellular Carcinoma.
    Liao H; Shi J; Wen K; Lin J; Liu Q; Shi B; Yan Y; Xiao Z
    J Hepatocell Carcinoma; 2021; 8():985-996. PubMed ID: 34466409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis: a new promising target for hepatocellular carcinoma therapy.
    Xu Q; Ren L; Ren N; Yang Y; Pan J; Zheng Y; Wang G
    Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38051404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis in hepatocellular carcinoma, from mechanism to effect.
    Jiang S; Zhang G; Ma Y; Wu D; Xie D; Zhou S; Jiang X
    Front Oncol; 2024; 14():1350011. PubMed ID: 38511140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ferroptosis in hepatocellular carcinoma.
    Nie J; Lin B; Zhou M; Wu L; Zheng T
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis: a new hunter of hepatocellular carcinoma.
    Jiang Y; Yu Y; Pan Z; Glandorff C; Sun M
    Cell Death Discov; 2024 Mar; 10(1):136. PubMed ID: 38480712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells.
    LoBianco FV; Krager KJ; Johnson E; Godwin CO; Allen AR; Crooks PA; Compadre CM; Borrelli MJ; Aykin-Burns N
    Front Toxicol; 2022; 4():936149. PubMed ID: 36591540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma
    Qin Y; Pei Z; Feng Z; Lin P; Wang S; Li Y; Huo F; Wang Q; Wang Z; Chen ZN; Wu J; Wang YF
    Front Cell Dev Biol; 2021; 9():751593. PubMed ID: 34977009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ferroptosis in hepatocellular carcinoma.
    Mo Y; Zou Z; Chen E
    Hepatol Int; 2024 Feb; 18(1):32-49. PubMed ID: 37880567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
    Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
    Front Oncol; 2021; 11():657723. PubMed ID: 34485112
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li Y; Zhang J; Zhang K; Chen Y; Wang W; Chen H; Zou Z; Li Y; Dai M
    Front Oncol; 2022; 12():693395. PubMed ID: 35321425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
    Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
    Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma.
    Wang S; Chen L; Liu W
    Cancer Cell Int; 2022 Oct; 22(1):318. PubMed ID: 36229881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
    Bekric D; Ocker M; Mayr C; Stintzing S; Ritter M; Kiesslich T; Neureiter D
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma.
    Ke S; Wang C; Su Z; Lin S; Wu G
    Front Genet; 2022; 13():897683. PubMed ID: 35651950
    [No Abstract]   [Full Text] [Related]  

  • 17. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
    Li Y; Xia J; Shao F; Zhou Y; Yu J; Wu H; Du J; Ren X
    Biochem Biophys Res Commun; 2021 Jan; 534():877-884. PubMed ID: 33162029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
    Lu Z; Yang H; Shao Y; Sun W; Jiang Y; Li J
    Biochem Biophys Res Commun; 2022 Oct; 627():103-110. PubMed ID: 36030651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma.
    Yang L; Guan Y; Liu Z
    Front Pharmacol; 2023; 14():1177405. PubMed ID: 37124203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.